Three Cryptocurrencies to Hold in 2021
In 2021, Dogecoin went up over 12,000%. SafeMoon went up more than 20,000%...

But if you missed those gains, there is still time to get in on the digital currency boom.

Luke Lango – InvestorPlace’s resident crypto expert – just released the names of 3 tokens every investor should own in a free report.
Click here to claim your copy today.

LGVN Insider Trading (Longeveron)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $805.00
Insider Selling (Last 12 Months): $0.00

Longeveron Insider Trading History Chart

This chart shows the insider buying and selling history at Longeveron by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Longeveron Share Price & Price History

Current Price: $5.72
Price Change: Price Decrease of -0.06 (-1.04%)
As of 07/30/2021 02:41 PM ET

This chart shows the closing price history over time for LGVN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
This stock could soar as cannabis beverage sales hit $2.5 billion
A popular Seattle cannabis manufacturer is now partnering with other companies to produce a new line of cannabis-infused beverages. It’s perfect timing. A new report reveals cannabis beverage sales will reach $2.8 billion by 2025, expanding at an annual compounded rate of 17.8%. A huge opportunity!
Find out why this could be the #1 penny stock

Longeveron Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/12/2021Rock SofferDirectorBuy100$8.05$805.00View SEC Filing Icon  
See Full Table
Insider Trading at Longeveron?
Sign-up to receive's daily insider buying and selling report for Longeveron and related companies.

SEC Filings (Institutional Ownership Changes) for Longeveron (NASDAQ:LGVN)

0.45% of Longeveron stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Longeveron Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/13/2021Matrix Asset Advisors Inc. NY30,000$0.20M0.0%N/A0.158%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Longeveron Inc., a clinical stage biotechnology company, engages in developing cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. It is conducting Phase 1 and 2 clinical trials in various indications comprising aging frailty, alzheimer's disease, metabolic syndrome, acute respiratory distress syndrome, and hypoplastic left heart syndrome. The company was incorporated in 2014 and is headquartered in Miami, Florida.
Read More on Longeveron

Today's Range

Now: $5.72
Low: $5.72
High: $5.87

50 Day Range

MA: $6.94
Low: $5.78
High: $8.30

52 Week Range

Now: $5.72
Low: $5.15
High: $12.48


1,160 shs

Average Volume

542,843 shs

Market Capitalization

$108.59 million

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Longeveron?

Longeveron's top insider shareholders include:
  1. Rock Soffer (Director)
The Dark Side Of The Electric Vehicle Boom
There's not enough of this valuable resource to meet demand. But this company might change that...
Get The Inside Scoop Now